Halkuff Dawn

Director at XERS

Sold, on record
$431k
Dollars the filings state
Form 4 sales
2
Latest Jun 4, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • XERSXeris Biopharma Holdings, Inc.Director

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale XERSUnusual
    Aug 12, 2025 2025

    Sold 42,500 shares at $7.28 ($309k)

    Halkuff Dawn, Director

    No 10b5-1 planSold 27% of holdings ($1.1M position)115,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale XERSRoutine
    Jun 4, 2026 +296 days

    Sold 20,000 shares at $6.09 ($122k)

    Halkuff Dawn, Director

    10b5-1 planSold 17.4% of holdings ($700k position)95,000 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Halkuff Dawn
Source
Jun 4, 2026Jun 5, 2026XERSDirectorForm 4 sale20,000$122k17.4%RoutineSEC
Aug 12, 2025Aug 13, 2025XERSDirectorForm 4 sale42,500$309k27.0%UnusualSEC